The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-[1-[(3,5-dimethylisoxazol-4-yl)methyl]pyrazol-4-yl]-1-[(2,5-dimethylpyrazol-3-yl)methyl]imidazolidine-2,4-dione ID: ALA4514970
PubChem CID: 57422494
Max Phase: Preclinical
Molecular Formula: C18H21N7O3
Molecular Weight: 383.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cc(CN2CC(=O)N(c3cnn(Cc4c(C)noc4C)c3)C2=O)n(C)n1
Standard InChI: InChI=1S/C18H21N7O3/c1-11-5-14(22(4)20-11)7-23-10-17(26)25(18(23)27)15-6-19-24(8-15)9-16-12(2)21-28-13(16)3/h5-6,8H,7,9-10H2,1-4H3
Standard InChI Key: OFZGBITWRBELBF-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
4.4904 -14.1358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.3117 -14.1358 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5661 -13.3550 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9031 -12.8687 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.2402 -13.3550 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0092 -14.7963 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3478 -13.0994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7954 -14.7975 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6123 -14.7130 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1576 -15.3250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9086 -14.9935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8241 -14.1765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0209 -14.0017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6200 -15.4029 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7022 -16.2169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5052 -16.3865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9147 -15.6751 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.3646 -15.0660 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5315 -14.2660 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7273 -15.5885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2086 -16.2489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0941 -16.7629 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9539 -17.0218 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6158 -17.5012 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.2762 -17.0198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0225 -16.2431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0538 -17.2712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1764 -17.2733 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 1 2 0
1 6 1 0
3 7 1 0
2 8 1 0
8 9 1 0
9 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 9 1 0
11 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 14 1 0
18 19 2 0
17 20 1 0
20 21 1 0
15 22 2 0
21 23 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 21 2 0
25 27 1 0
23 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 383.41Molecular Weight (Monoisotopic): 383.1706AlogP: 1.55#Rotatable Bonds: 5Polar Surface Area: 102.29Molecular Species: NEUTRALHBA: 8HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.88CX Basic pKa: 2.98CX LogP: -0.29CX LogD: -0.29Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.62Np Likeness Score: -2.03
References 1. Fotsing JR, Darmohusodo V, Patron AP, Ching BW, Brady T, Arellano M, Chen Q, Davis TJ, Liu H, Servant G, Zhang L, Williams M, Saganich M, Ditschun T, Tachdjian C, Karanewsky DS.. (2020) Discovery and Development of S6821 and S7958 as Potent TAS2R8 Antagonists., 63 (9): [PMID:32330040 ] [10.1021/acs.jmedchem.0c00388 ]